Myocarditis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …

Importance Increased rates of myocarditis or pericarditis following receipt of COVID-19
mRNA vaccines have been observed. However, few available data are associated with …

Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

Importance Active monitoring of health outcomes after COVID-19 vaccination offers early
detection of rare outcomes that may not be identified in prelicensure trials. Objective To …

Concerns have been raised recently about takotsubo cardiomyopathy (TCM) after receiving
COVID-19 vaccines, particularly the messenger RNA (mRNA) vaccines. The goal of this …

Importance Active monitoring of health outcomes after COVID-19 vaccination provides early
detection of rare outcomes that may not be identified in prelicensure trials. Objective To …

Myocarditis is defined as a non-ischemic inflammatory disease of the myocardium. It
remains a challenge to diagnose given non-specific symptoms and lack of specific blood …

Monkeypox virus has emerged in different parts of the world with varying clinical symptoms
and outcomes. To date, only a few studies have reported cardiac manifestations among …

Aims To prospectively evaluate the incidence of myocardial injury after the administration of
the fourth dose BNT162b2 mRNA vaccine (Pfizer‐BioNTech) against COVID‐19. Methods …